Jubilant Biosys and Collaborative Drug Discovery (CDD) said that Jubilant has chosen CDD Vault as their discovery research informatics platform for the next five years. Jubilant will be using CDD Vault as their informatics platform to facilitate and boost transparent distribution of research data and information. CDD Vault manages biological assay data, involved chemical structures, reactions and compound properties.
 
“CDD Vault will be used across Jubilant research sites; to keep experimental information centralized, both structured and unstructured, to share with clients,” said Marcel Velterop, president of drug discovery services and CDMO, Jubilant Biosys Limited. “Scientists will be able to explore their chemistry and biology data in real-time, enabling rapid decision-making of discovery programs with CDD Vault.”
 
Mariana Vaschetto, general manager, CDD Global Business, said, “Jubilant is a leading collaborator for pharmaceutical and biotechnology companies worldwide and we are delighted to assist them in sharing their high quality preclinical R&D services with the life science industry. CDD Vault has been designed for collaborative research within or between organizations in a secure and easy to use way. We are looking forward to this long term relationship with Jubilant and helping them ensure the success of their customers’ research.”
 
CDD’s flagship product, CDD Vault, is used to manage chemical registration, structure activity relationships (SAR) and securely scale collaborations. It is a hosted database solution for secure management and sharing of biological and chemical data and designed to let the user intuitively organize chemical structures and biological study data and collaborate with internal or external partners through a web interface. Available modules include Activity & Registration, Visualization, Inventory and ELN.